KYNTRA BIO, INC. Available-for-sale Securities, Amortized Cost Basis
KYNTRA BIO, INC. (KYNB) had Available-for-sale Securities, Amortized Cost Basis of $354.43 million as of 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2021-11-09
- 2021-09-30: Available-for-sale Securities, Amortized Cost Basis $354.43M.
- 2021-06-30: Available-for-sale Securities, Amortized Cost Basis $259.53M.
- 2021-03-31: Available-for-sale Securities, Amortized Cost Basis $204.34M.
- 2020-12-31: Available-for-sale Securities, Amortized Cost Basis $8.27M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2021-09-30 | $354.43M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $259.53M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $204.34M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $8.27M 10-Q · filed 2021-11-09 |
| 2020-09-30 | $155.12M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $255.24M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $411.36M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $467.85M 10-K · filed 2021-03-01 |
| 2019-09-30 | $442.17M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $595.85M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $615.24M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $587.88M 10-K · filed 2020-03-02 |
| 2018-09-30 | $126.53M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $38.60M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $53.95M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $71.36M 10-K · filed 2019-02-27 |
| 2017-09-30 | $94.17M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $107.48M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $125.76M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $150.02M 10-K · filed 2018-02-27 |
| 2016-09-30 | $141.47M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $150.63M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $153.90M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $159.92M 10-K · filed 2017-03-01 |
| 2015-09-30 | $140.64M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $150.24M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $153.05M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $158.82M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |